Found: 1
Select item for more details and to access through your institution.
Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: An updated systematic review and meta‐analysis including the 2‐year STEP 5 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 3, p. 911, doi. 10.1111/dom.15386
- By:
- Publication type:
- Article